Table 5.
MTS+TSGT | TI+TSGT | USUAL CARE | |
---|---|---|---|
Number (and range) of sessions | All participants (n = 19) received 20 sessions of both MTS and TSGT | 13 participants received all 20 sessions; one participant received two TSGT sessions (2–20) | MTS+TSGT: 181 (0–22) TI+TSGT: 195 (0–43) |
Mean (SD) number of sessions per participant | 20.00 (0.00) | 18.62 (4.99) | MTS+TSGT: 9.53 (5.62) TI+TSGT: 15.00 (11.99) |
Prescribed dose (minutes) | MTS: 30–60 TSGT: 30 |
TIs: >30 TSGT: 30 |
N/A |
Actual dose delivered (fidelity) [mean (SD); range in minutes] | MTS: 31.15 (3.47); 22–54 TSGT: 29.03 (2.58); 18.75–30.20 |
TIs: 462 (48); 30–720 TSGT: 30.21 (0.92); 29.25–32.65 |
MTS+TSGT: 44.44 (12.48) [Lower limb focused 37.71 (21.31); upper limb focused 19.85 (22.62)] TI+TSGT: 43.28 (14.61) [lower limb focused 44.86 (15.65); upper limb focused 16.98 (22.39)] |
Adherence rate* | MTS: 94.74% TSGT: 94.74% (18 of 19 participants) |
TIs: 100% TSGT: 100% (all 13 participants) |
N/A |
Measured as percentage of intervention delivered to protocol i.e., 30–60 min of MTS; >30 min of wearing TI.
TSGT—within 10% of the specified 30 min; N/A, not applicable.
MTS, Mobilization and tactile stimulation; SD, Standard deviation; TI, Textured insoles; TSGT, Task-specific gait training.